Syndax Pharmaceuticals (SNDX) EBIT Margin Growth (5y) (2020 - 2026)
Syndax Pharmaceuticals (SNDX) EBIT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
711,429.00 |
| Dec 31, 2025 |
513,531.00 |
| Sep 30, 2025 |
511,307.00 |
| Jun 30, 2025 |
419,988.00 |
| Mar 31, 2025 |
356,626.00 |
| Dec 31, 2024 |
248,341.00 |
| Sep 30, 2024 |
275,278.00 |
| Jun 30, 2024 |
193,601.00 |
| Dec 31, 2021 |
372,843.00 |
| Sep 30, 2021 |
483,419.00 |
| Jun 30, 2021 |
-306,206.00 |
| Mar 31, 2021 |
-429,718.00 |
| Dec 31, 2020 |
-369,222.00 |
| Sep 30, 2020 |
-331,760.00 |
| Jun 30, 2020 |
2.82 Mn |
